Development and Validation of a Predictive Model Based on Serum Silent Information Regulator 6 Levels in Chinese Older Adult Patients: Cross-Sectional Descriptive Study
- Yuzi You 1, Wei Liang 2, Yajie Zhao 2
- Yuzi You 1, Wei Liang 2, Yajie Zhao 2
- 1Department of General Practice, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- 2Department of Geriatrics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, China, 86 13601893105.
- 0Department of General Practice, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Silent information regulator 6 (SIRT6) predicts coronary artery disease (CAD) severity in older adults. A nomogram combining SIRT6 and the triglyceride glucose (TyG) index enhances prediction accuracy for cardiovascular health.
Area Of Science
- Cardiovascular Medicine
- Biomarker Discovery
- Geriatric Medicine
Background
- Serum silent information regulator 6 (SIRT6) levels are linked to aging and coronary artery disease (CAD).
- The role of SIRT6 in differentiating the severity of coronary artery lesions in elderly patients remains unclear.
Purpose Of The Study
- To develop a predictive nomogram utilizing SIRT6 for assessing coronary artery atherosclerosis severity.
- To evaluate the efficacy of SIRT6 as a biomarker for CAD in older adults.
Main Methods
- A single-center study screened 222 patients aged 60+ with angina pectoris.
- Serum SIRT6 levels were measured via ELISA; clinical data and angiography were analyzed.
- An Extreme Gradient Boosting (XGBoost) model developed a nomogram, validated using 10-fold cross-validation.
Main Results
- Serum SIRT6 was an independent risk factor and predictor for CAD in older adults (AUROC 0.725).
- A nomogram integrating SIRT6, triglyceride glucose (TyG) index, and apolipoprotein B achieved high predictive accuracy (AUROC 0.956 in development, 0.913 in validation).
- The model demonstrated satisfactory calibration, with predicted outcomes closely matching actual results.
Conclusions
- SIRT6 shows significant potential for predicting CAD, especially when combined with the TyG index.
- The developed nomogram can aid in clinical trial design and personalized treatment decisions for older adults with angina.
- Monitoring SIRT6 and TyG index fluctuations may facilitate early detection and management of cardiovascular disease.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

